North London Chinese Association 北倫敦華人協會

Follow here: https://www.newham.gov.uk/carersweek

Book for free: https://www.tickettailor.com/events/stmarksbeckton/2222454

Our Chairside Chat series is back and we are excited to announce a special fundraising event with two remarkable humanitarians!

Dr Naseem Ghazali, a trustee of MERCY Humanitarian UK is an Oral & Maxillofacial-Head & Neck Surgeon that has done humanitarian work in Cambodia, Nepal, Morocco, and Gaza. She is joined by Dr Mariam Karimi, an anaesthetist who has worked with NGOs in Tanzania, Myanmar, Thailand, Gaza, and South Sudan.

🗓 Saturday, 13 June 2026
⏰ 2PM – 5PM
📍 Education Malaysia (Malaysia Hall), London,
W2 3ST.
🎟 Tickets: £20 | Students: £10
📲 Scan the QR code to purchase or via:
https://www.zeffy.com/en-GB/ticketing/chairside-chat-with-humanitarian-series-3
☕️: Light refreshments provided 🧁

Join us to listen, learn, and be inspired! 🤍

From Sky News: https://news.sky.com/story/uk-faces-economic-catastrophe-unless-it-adapts-to-young-people-rewired-by-smartphones-13547229?

The UK is facing an “economic catastrophe” unless it adapts to younger generations who have grown up in a digital world, a former minister has warned.

Alan Milburn is due to publish an interim report next week that examines why almost one million 16 to 24-year-olds are not in employment, education or training (NEET).

It will conclude that a “rising tide of mental ill health, anxiety, depression and neurodiversity” is a big factor in this economic inactivity.

Speaking to The Times, Mr Milburn rejected claims that young people are “snowflakes” – and said the country is at risk “of just writing a whole generation off”.

According to the report, the rise of smartphones and social media has led to a “bedroom generation” that suffers from poorer sleep and lower levels of concentration.

“Every one of a group of ten 12 and 13-year-olds told us they went to bed between midnight and 3am because they were scrolling on their phone,” it will warn.

The report will describe young people as different – and not worse, lazier or less intelligent than their peers in other age groups.

“They have grown up in a digital world that has rewired how they communicate, form relationships and manage stress,” it will say. “They have fewer experiences of workplaces, and they present with higher levels of anxiety and depression.”

COVID is also thought to have played a factor, as many 16 to 24-year-olds would have been in high school or college during lockdown closures.

Mr Milburn believes the UK’s one million NEETs could plug labour shortages in the British economy, as long as employers are willing to make accommodations for them.

Speaking to the newspaper, he went on to warn that welfare reforms will be a “necessity” to help younger generations enter the world of work.

Figures from the Office for National Statistics suggest youth unemployment reached 16.2% in the three months to March – the highest level in 11 years.

St Anne’s Limehouse is proud to launch a new
exhibition
The Original Chinatown: Myths and Realities
March 20th 2026 – July 2026

This exhibition celebrates the first London Chinatown
found right next to St Anne’s, which flourished
1900-1955, and had all but disappeared by the 1960’s.
Extraordinarily, this small community became the focus
of international attention through its portrayal in films,
fiction and popular music. Its depiction in the national
press was often sensationalist and scurrilous. And
myths created then were so powerful that they persist to
this day, long after Chinatown itself.
Yet Limehouse Chinatown was, in fact, an urban village,
where ordinary people lived, worked and went to school.
We have testaments and documents from families who
lived here and from people who visited here for work or
pleasure. We feature instillations by ceramicist Charles
Ng exploring the realities of daily life in this community.
The image of these four young girls illustrate how
Limehouse Chinatown was always an interracial
community. This was its great strength, but also a
factor in the community’s ultimate demise and,
unhappily, a trigger for some of the most pernicious
Sino-phobic mythologising ….
Andrew Humphrey will be running some of his superbly
researched walking tours of Chinese Limehouse to
coincide with the exhibition.
Other events in the church are to be arranged.
ENTRANCE IS FREE BUT DONATIONS FOR THE
CHURCH RESTORATION FUND ARE WELCOME
OPEN: THURSDAY, FRIDAYS, SATURDAYS 10- 4
CONTACT Philip Reddaway on philipcfsa@gmail.com

From Sky News: https://news.sky.com/story/new-pill-doubles-survival-time-for-pancreatic-cancer-patients-trial-finds-13549699?dcmp

Researchers found that the median survival time for patients on a drug called daraxonrasib was 13.2 months compared to 6.6 months for those receiving chemotherapy.

A new pill helped to double the survival time for patients with an advanced and aggressive form of pancreatic cancer when compared to chemotherapy, a trial has found.

The drug called daraxonrasib works by locking onto the mutated KRAS gene, which is found in more than 90% of pancreatic tumours.

The gene continuously signals cancer cells to grow, but the drug shuts this off, thereby stopping tumours from spreading.

Pancreatic Cancer UK said new treatments targeting the gene variant are “some of the most exciting developments” in a very long time, and called for clinical trials in the UK.

The trial, presented at the American Society of Clinical Oncology annual meeting in Chicago, compared 500 patients with advanced pancreatic cancer which had spread to other organs.

The patients, based in North America, Europe and Asia, had previously received treatment and were still able to carry out most of their daily activities.

Some 248 of them were given darazonrasib, while the other 252 received chemotherapy. Most of them had tumours with specific mutations of the KRAS gene.

Researchers found that the median survival time for patients on daraxonrasib was 13.2 months compared to 6.6 months for those on chemotherapy.

The median time without cancer progression was similar in both groups, at 7.3 months for those on daraxonrasib and 7.2 months for chemotherapy patients.

The study also found that daraxonrasib resulted in fewer serious side effects, with 43.6% of patients on the drug experiencing severe side effects, compared to 57.5% of those receiving chemotherapy.

Just 1.2% of people in the daraxonrasib group stopped treatment because of side effects compared to 11.2% of the chemotherapy group.

Anna Jewell, director of services, research and innovation at Pancreatic Cancer UK, hailed darazonrasib as one of the “most exciting developments” in pancreatic cancer treatment, as patients were given “months more precious time with their loved ones”.

“Crucially, these results suggest that daraxonrasib is able to keep the cancer under control for longer,” Ms Jewell said.

“There are now several KRAS inhibitor drugs in clinical trials around the world, which are showing promising results.

“We now need to ensure that these clinical trials are available in the UK, and that crucially these new treatment types are fast-tracked for approval – as recognised in the National Cancer Plan.”